Marked reductions in visual impairment due to diabetic retinopathy achieved by efficient screening and timely treatment
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Purpose: Diabetic retinopathy (DR) is the most common complication of diabetes and needs to be diagnosed early to prevent severe sight‐threatening retinopathy. Digital photography with telemedicine connections is a novel way to deliver cost‐effective, accessible screening to remote areas. Screening for DR in a mobile eye examination unit (EyeMo) is compared to traditional service models (i.e. local municipal services or a commercial service provider). The quality of images, delays from screening to treatment, the stage of DR, coverage of screening and the rate of visual impairment due to DR are evaluated. Methods: EyeMo utilizes telemedicine technology. The electronic databases of the hospital and information from the Finnish Register of Visual Impairment were used to determine delays and the rate of visual impairment. Results: Fourteen thousand eight hundred and sixty‐six fundus photographs were taken in EyeMo in 2007–2011. Coverage reached 78% of potential clients. No DR was detected in 43%, mild background retinopathy in 23%, moderate or severe background retinopathy in 31% and proliferative retinopathy in 3% of the evaluations. The quality of images was higher (p < 0.01) and delays shorter (p < 0.01) in EyeMo as compared to traditional service models. The rate of visual impairment due to DR decreased by 86% in the area covered by EyeMo, and the change compared favourably to the situation in the entire Finland (p < 0.0005). Conclusion: EyeMo is a feasible model of telemedicine application for screening of DR. Effective screening and timely access to care may indeed have influenced the reduced rate of visual damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985 · cited 1×
“The global prevalence of type 2 diabetes has been increasing in an exponential manner, and current projections estimate that 439 million adults will be affected by 2030 (Shaw et al. 2010; Yau et al. 2012).”
BackgroundCheung, N., Mitchell, P., & Wong, T. Y. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62124-3 · Cited by 3,288
Cited by
Virgili, G., Menchini, F., Casazza, G., Hogg, R., Das, R. R., Wang, X., & Michelessi, M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008081.pub3 · Cited by 265
Mansberger, S. L., Sheppler, C., Barker, G., Gardiner, S. K., Demirel, S., Wooten, K., & Becker, T. M. (2015) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2015.1 · Cited by 177
The Empirical Evidence for the Telemedicine Intervention in Diabetes Management
Bashshur, R. L., Shannon, G. W., Smith, B. R., & Woodward, M. A. (2015) · Telemedicine and e-Health · doi:10.1089/tmj.2015.0029 · Cited by 102
(2020) · doi:10.1007/s00592-020-01585-7 · Cited by 57
Metadata
- Authors
- Hautala, N., Aikkila, R., Korpelainen, J., Keskitalo, A., Kurikka, A., Falck, A., Bloigu, R., & Alanko, H.
- Venue
- Acta Ophthalmologica
- Publisher
- Wiley
- Published
- 2013-10-17
- Volume
- 92
- Issue
- 6
- Pages
- 582-587
- ISSN
- 0001-639X (ISSN-L)
- 1755-375X
- 1755-3768
- OpenAlex
- W2039898368
- Cited by
- 77
- References
- 2
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Marked reductions in visual impairment due to diabetic retinopathy achieved by efficient screening and timely treatment. https://app.cochat.ai/papers/10.1111/aos.12278
- The paper
- Hautala, N., Aikkila, R., Korpelainen, J., Keskitalo, A., Kurikka, A., Falck, A., Bloigu, R., & Alanko, H. (2014). Marked reductions in visual impairment due to diabetic retinopathy achieved by efficient screening and timely treatment. Acta Ophthalmologica. https://doi.org/10.1111/aos.12278
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.